Chemical Formula: C36H60O6

Chemical Formula C36H60O6

Found 172 metabolite its formula value is C36H60O6

DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0)

(2S)-3-hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0)

(2S)-2-hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0)

(2S)-3-hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0)

(2S)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Basilimoside

(2R,3R,4S,5S,6R)-2-{[(1S,2R,5S,10S,11S,14R,15R)-14-[(2R,3E)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


Basilimoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Basilimoside can be found in sweet basil, which makes basilimoside a potential biomarker for the consumption of this food product.

   

Basilimoside

Basilimoside

C36H60O6 (588.4389659999999)


   

alpha-amyrin-3-O-beta-D-glucopyranoside

alpha-amyrin-3-O-beta-D-glucopyranoside

C36H60O6 (588.4389659999999)


   

Ginsenoside RK2

Ginsenoside RK2

C36H60O6 (588.4389659999999)


   

peruvianursenyl glucoside|urs-12-en-18alphaH-3beta-O-beta-D-glucopyranoside

peruvianursenyl glucoside|urs-12-en-18alphaH-3beta-O-beta-D-glucopyranoside

C36H60O6 (588.4389659999999)


   

(3beta,18alpha,19alpha)-urs-20(30)-en-3-yl beta-D-glucopyranoside|3-O-beta-D-glucopyranosyltaraxasterol|taraxasterol-3-O-beta-D-glucoside

(3beta,18alpha,19alpha)-urs-20(30)-en-3-yl beta-D-glucopyranoside|3-O-beta-D-glucopyranosyltaraxasterol|taraxasterol-3-O-beta-D-glucoside

C36H60O6 (588.4389659999999)


   

beta-amyrin- beta-D-glucopyranoside|beta-amyrin-beta-D-glucopyranoside

beta-amyrin- beta-D-glucopyranoside|beta-amyrin-beta-D-glucopyranoside

C36H60O6 (588.4389659999999)


   

24-isopropyl-5alpha-cholestane-2beta,3alpha,6alpha-triol triacetate

24-isopropyl-5alpha-cholestane-2beta,3alpha,6alpha-triol triacetate

C36H60O6 (588.4389659999999)


   

C36H60O6

C36H60O6 (588.4389659999999)


   

Triisononyl trimellitate

Triisononyl trimellitate

C36H60O6 (588.4389659999999)


   

trinonyl benzene-1,2,4-tricarboxylate

trinonyl benzene-1,2,4-tricarboxylate

C36H60O6 (588.4389659999999)


   

DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

(2-nonanoyloxy-3-octanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(2-nonanoyloxy-3-octanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C36H60O6 (588.4389659999999)


   

TG(33:4)

TG(16:0_6:0_11:4)

C36H60O6 (588.4389659999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

CAE 12:1

CAE 12:1

C36H60O6 (588.4389659999999)


   

7,8-bis(acetyloxy)-1-(5-isopropyl-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

7,8-bis(acetyloxy)-1-(5-isopropyl-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6br,8ar,12s,12ar,12br,14ar,14br)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6br,8ar,12s,12ar,12br,14ar,14br)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

2-{[1-(5-ethyl-6,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8s,11s,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8s,11s,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

2-[(4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

4-[(4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-2,3,5-triol

4-[(4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-2,3,5-triol

C36H60O6 (588.4389659999999)


   

(1r,3as,3bs,5s,5as,7s,8s,9ar,9bs,11ar)-7,8-bis(acetyloxy)-1-[(2r)-5-isopropyl-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

(1r,3as,3bs,5s,5as,7s,8s,9ar,9bs,11ar)-7,8-bis(acetyloxy)-1-[(2r)-5-isopropyl-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C36H60O6 (588.4389659999999)


   

2-(hydroxymethyl)-6-{[7,12,16-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[7,12,16-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5r,6r)-4-{[(3r,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

(2r,3r,4s,5r,6r)-4-{[(3r,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8r,11r,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8r,11r,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(3r,4s,5s,6r)-2-{[(3ar,3bs,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-3b,9a,11a-trimethyl-1h,2h,3h,3ah,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(3r,4s,5s,6r)-2-{[(3ar,3bs,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-3b,9a,11a-trimethyl-1h,2h,3h,3ah,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5r,6r)-4-{[(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

(2r,3r,4s,5r,6r)-4-{[(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)